TARSONS PRODUCTS share price has plunged 4% and is presently trading at Rs 418.1.
Meanwhile, the BSE HEALTHCARE index is at 44,476.9 (up 0.1%).
Among the top losers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (down 3.3%) and DR. LAL PATHLABS (down 2.4%).
POLY MEDICURE (up 5.6%) and HIKAL CHEMIC (up 2.4%) are among the top gainers today.
Over the last one year, TARSONS PRODUCTS has moved down from Rs 516.8 to Rs 418.1, registering a loss of Rs 98.7 (down 19.1%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,004.5 to 44,476.9, registering a gain of 58.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 173.4%), Glenmark Pharma (up 128.8%) and SUVEN PHARMACEUTICALS (up 112.0%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,881.5 (up 0.6%).
The top gainers among the BSE Sensex today are L&T (up 1.9%) and HDFC Bank (up 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 25,100.2 (up 0.5%). Wipro and L&T are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,079.4 to 81,881.5, registering a gain of 15,802.1 points (up 23.9%).
TARSONS PRODUCTS net profit fell 58.1% YoY to Rs 40 million for the quarter ended June 2024, compared to a profit of Rs 96 million a year ago. Net sales rose 35.5% to Rs 848 million during the period as against Rs 626 million in April-June 2023.
For the year ended March 2024, TARSONS PRODUCTS reported 47.2% decrease in net profit to Rs 426 million compared to net profit of Rs 807 million during FY23. Revenue of the company grew 4.6% to Rs 2,964 million during FY24.
The current Price to earnings ratio of TARSONS PRODUCTS, based on rolling 12 month earnings, stands at 60.0.
Equitymaster requests your view! Post a comment on "TARSONS PRODUCTS Plunges 4%; BSE HEALTHCARE Index Up 0.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!